BioNTech SE Total Current Liabilities 2019-2024 | BNTX

BioNTech SE total current liabilities for the quarter ending September 30, 2024 were $2.774B, a 41.02% increase year-over-year.

  • BioNTech SE total current liabilities for 2023 were $2.241B, a 27.92% decline from 2022.
  • BioNTech SE total current liabilities for 2022 were $3.109B, a 24.53% decline from 2021.
  • BioNTech SE total current liabilities for 2021 were $4.119B, a 495.03% increase from 2020.

BioNTech SE Total Current Liabilities 2019-2024 | BNTX

  • BioNTech SE total current liabilities for 2023 were $2.241B, a 27.92% decline from 2022.
  • BioNTech SE total current liabilities for 2022 were $3.109B, a 24.53% decline from 2021.
  • BioNTech SE total current liabilities for 2021 were $4.119B, a 495.03% increase from 2020.